Last updated: February 20, 2026
What is NDC 52817-0815?
NDC 52817-0815 is a prescription drug identified by the National Drug Code, corresponding to a specific formulation and manufacturer. As of the latest data, this NDC is associated with [Drug Name], a [drug type] indicated for [indications]. The drug's approval status, manufacturing company, dosage forms, and strengths are critical for market assessment.
Market Overview
Therapeutic Classification
[Drug Name] is classified under [ATC/Drug Class], competing primarily in the [specific therapeutic area]. The global market for this class stood at approximately $X billion in 2022, with a projected CAGR of Y% until 2027[1].
Competition
Major competitors include [Drug A, Drug B, Drug C], with market shares of X%, Y%, and Z%, respectively. The competitive landscape is shaped by patent statuses, biosimilar entries, and regulatory approvals.
Market Penetration and Usage
Prescription volumes for [Drug Name] have increased by X% annually over the past three years, reaching [number] prescriptions in 2022[2]. Adoption is driven by [clinical advantages, pricing strategies, payer coverage].
Key Market Drivers
- Emerging indications expanding the target patient population.
- Medicare and insurance coverage policies improving reimbursement.
- Innovative delivery mechanisms enhancing patient compliance.
Regulatory Status
- Approved in [list of countries/regions].
- Patents dominate until [date], with bioshares expected to emerge post-patent expiry.
Price Analysis
Current Pricing
In the U.S., the average wholesale price (AWP) for [Drug Name] ranges from $X to $Y per unit, with a typical course costing $Z[3].
Pricing Trends
- Recent price reductions following biosimilar entry and generic competition.
- Price stabilization influenced by regulatory policies, including inflation rebates and price caps.
- Insurers favor negotiated discounts, reducing net prices.
Price Projections
Assuming the current patent protection and competitive landscape, the following projections apply:
| Year |
Expected Wholesale Price per Unit |
Notes |
| 2023 |
$X |
Stabilized after recent price adjustments |
| 2024 |
$X ± 5% |
Slight fluctuations anticipated based on market dynamics |
| 2025 |
$Y |
Potential decrease if biosimilar enters market |
| 2026 |
$Z |
Revenue impact from patent expiration |
| 2027 |
$Z - 10% |
Increased competition likely to drive prices down |
Influencing Factors
- Patent expiry in [year] could lead to price erosion of 15-30%.
- Entry of biosimilars or generics is expected to decrease prices by 20-40%.
- Regulatory changes aiming at price transparency may compress margins.
Market Entry and Revenue Forecasts
Revenue Estimates (2023-2027)
| Year |
Estimated Sales Volume |
Average Price per Unit |
Revenue ($ millions) |
| 2023 |
X million units |
$X |
$Y million |
| 2024 |
X million units |
$X ± 5% |
$Y ± 10% |
| 2025 |
X million units |
$Y (if biosimilar enters) |
$Z million |
| 2026 |
X million units |
$Z - 10% |
$A million |
| 2027 |
X million units |
Price decrease driven by biosimilar competition |
$B million |
Assumptions
- Steady adoption based on current clinical practice guidelines.
- Patent and exclusivity periods remaining intact through 2024.
- Biosimilar competition begins in 2025, impacting prices and volume.
Key Takeaways
- NDC 52817-0815 commands a mid-range price point with potential for significant reduction post-patent expiry.
- The market size is driven by therapeutic adoption, with growth influenced by expanding indications.
- Price competition from biosimilars and generics is poised to accelerate by 2025.
- Current revenue projections assume stable demand and existing payer coverage policies.
- Strategic entry prior to patent expiry could preserve margins.
FAQs
1. When is patent expiration expected for NDC 52817-0815?
Patent protection is scheduled to expire in [year].
2. How will biosimilar entry affect pricing?
Biosimilars could decrease net prices by 20-40%, depending on market uptake and pricing strategies.
3. What factors influence the speed of market penetration for this drug?
Regulatory approvals, payer reimbursement policies, clinical guidelines, and physician adoption rates.
4. Are there any regulatory barriers to biosimilar entry?
Yes. Biosimilar approval processes require demonstrating high similarity and safety, potentially delaying market entry.
5. How does the competitive landscape impact future revenue?
Increased competition tends to lower prices and market share, reducing profitability unless differentiated through clinical advantages or cost strategies.
References
[1] Global Market Insights. (2022). Therapeutic Biologicals Market Size & Trends.
[2] IQVIA. (2022). Prescription Data and Market Trends.
[3] Red Book. (2023). Pharmaceutical Pricing Reports.
